Finance entity
All 1 tracked stories fall under one category: regulation. Amgen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 4 original sources on average, compared with 2.1 for the broader beat in this window.
Last mentioned: Jul 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Amgen is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 4 original sources on average, compared with 2.1 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.9. We currently track 1 Finance story that mention HIV+Hepatitis Policy Institute, all published on July 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering HIV+Hepatitis Policy Institute. Shared-story counts are live from our verified record — not editorial picks.
Oscar Health's use of a copay accumulator program has drawn attention to how insurers manage medical loss ratios. By not counting manufacturer assistance, insurers keep claims low, but regulatory and reputational risks could affect investor outlook.
HIV+Hepatitis Policy Institute is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
